Nelson, Van Denburg & Campbell Wealth Management Group, LLC Kura Oncology, Inc. Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.42 Billion
Q3 2024

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$13.42 - $23.53 $187 - $329	14 New	14 $0
Q1 2020 Apr 01, 2020	SELL	$6.45 - $14.04 $645 - $1,404	-100 Closed	0 $0
Q3 2019 Oct 09, 2019	BUY	$14.75 - $20.87 $737 - $1,043	50 Added 100.0%	100 $1,000
Q4 2018 Feb 13, 2019	SELL	$10.6 - $17.49 $2,650 - $4,372	-250 Reduced 83.33%	50 $0
Q1 2018 May 15, 2018	BUY	$14.5 - $23.4 $3,625 - $5,850	250 Added 500.0%	300 $6,000
Q3 2017 Nov 08, 2017	SELL	$6.05 - $14.95 $2,117 - $5,232	-350 Reduced 87.5%	50 $1,000
Q2 2017 Aug 15, 2017	BUY	N/A	400	400 $4,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

Suvretta Capital Management, LLC New York, NY

7.65M
Shares

$68.4 Million
5.88% of portfolio
Black Rock Inc. New York, NY

6.97M
Shares

$62.3 Million
0.0% of portfolio
Eco R1 Capital, LLC San Francisco, CA

5.81M
Shares

$51.9 Million
4.92% of portfolio
Deerfield Management Company, L.P. (Series C) New York, NY

5.41M
Shares

$48.4 Million
1.97% of portfolio
Paradigm Biocapital Advisors LP New York, NY

4.33M
Shares

$38.7 Million
3.05% of portfolio

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account